RFC
ARNA

Russell Frank Company’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Russell Frank Company’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,170
Closed -$40K – 3072
2014
Q4 		$40K Buy
+1,170
New +$47.5K ﹤0.01% 2818
2013
Q4 		– Sell
-8,344
Closed -$440K – 3152
2013
Q3 		$440K Buy
8,344
+714
+9% +$47.9K ﹤0.01% 2534
2013
Q2 		$635K Buy
+7,630
New +$623K ﹤0.01% 2244

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Russell Frank Company's ARNA Position: Q1 2015 in Review

Russell Frank Company sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2015, closing a stake of 1,170 shares — an estimated $40K sold.

Russell Frank Company first reported a position in ARNA in Q2 2013 and held it in 3 quarters. The position peaked at $635K in Q2 2013. 122 funds tracked by Wall St. Rank hold ARNA as of Q1 2015.

  • Russell Frank Company reported no remaining Arena Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Russell Frank Company sold 1,170 Arena Pharmaceuticals Inc shares in Q1 2015, an estimated $40K.
  • Russell Frank Company first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • Russell Frank Company's Arena Pharmaceuticals Inc position peaked at $635K in Q2 2013.
  • 122 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2015.

Based on Russell Frank Company's 13F filing for Q1 2015, filed 13 May 2015.